News

iCAD has received CE mark approval to market and sell its customized solution with Planmed Nuance mammography systems and units have been placed at Terveystalo Breast Cancer Screening

Under the terms of purchase agreements, XenoPort will sell 1.89 million newly issued shares of its common stock and warrants to purchase 283,420 shares of common stock at

Joseph Army, president and CEO of Salient, said: “This new facility provides exciting opportunities for our continued growth. It brings many new capabilities to our corporate office, including

The funds will be used for general corporate purposes. The financing gives the company the right to place common stock to the investors at a 3% discount to

In addition, FDA has designated the submission for priority review, with a review goal date of April 30, 2009. Northfield had previously submitted the biologics license application (BLA)

AutoPulse is an automated, portable device with an easy-to-use, load-distributing LifeBand that squeezes the entire chest in an uninterrupted hands-free manner, improving blood flow to the heart and

Stavudine capsules, indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents, are the generic version of Bristol-Myers Squibb’s Zerit capsules. The product was shipped

The Phase II clinical trial is a multicenter, randomized, double-blind, placebo-controlled study assessing the analgesic efficacy and safety of T-62 in subjects with postherpetic neuralgia and its associated

According to the terms of Johnson & Johnson’s tender offer, shares that were validly tendered and not withdrawn have been accepted for payment. The tender offer expired on